Literature DB >> 19333130

Coupled calcium and zinc dyshomeostasis and oxidative stress in cardiac myocytes and mitochondria of rats with chronic aldosteronism.

German Kamalov1, Prajwal A Deshmukh, Narina Y Baburyan, Malay S Gandhi, Patti L Johnson, Robert A Ahokas, Syamal K Bhattacharya, Yao Sun, Ivan C Gerling, Karl T Weber.   

Abstract

A dyshomeostasis of extra- and intracellular Ca(2+) and Zn(2+) occurs in rats receiving chronic aldosterone/salt treatment (ALDOST). Herein, we hypothesized that the dyshomeostasis of intracellular Ca(2+) and Zn(2+) is intrinsically coupled that alters the redox state of cardiac myocytes and mitochondria, with Ca(2+) serving as a pro-oxidant and Zn(2+) as an antioxidant. Toward this end, we harvested hearts from rats receiving 4 weeks of ALDOST alone or cotreatment with either spironolactone (Spiro), an aldosterone receptor antagonist, or amlodipine (Amlod), an L-type Ca(2+) channel blocker, and from age/sex-matched untreated controls. In each group, we monitored cardiomyocyte [Ca(2+)]i and [Zn(2+)]i and mitochondrial [Ca(2+)]m and [Zn(2+)]m; biomarkers of oxidative stress and antioxidant defenses; expression of Zn transporters, Zip1 and ZnT-1; metallothionein-1, a Zn(2+)-binding protein; and metal response element transcription factor-1, a [Zn(2+)]i sensor and regulator of antioxidant defenses. Compared with controls, at 4-week ALDOST, we found the following: (a) increased [Ca(2+)]i and [Zn(2+)]i, together with increased [Ca(2+)]m and [Zn(2+)]m, each of which could be prevented by Spiro and attenuated with Amlod; (b) increased levels of 3-nitrotyrosine and 4-hydroxy-2-nonenal in cardiomyocytes, together with increased H(2)O(2) production, malondialdehyde, and oxidized glutathione in mitochondria that were coincident with increased activities of Cu/Zn superoxide dismutase and glutathione peroxidase; and (c) increased expression of metallothionein-1, Zip1 and ZnT-1, and metal response element transcription factor-1, attenuated by Spiro. Thus, an intrinsically coupled dyshomeostasis of intracellular Ca(2+) and Zn(2+) occurs in cardiac myocytes and mitochondria in rats receiving ALDOST, where it serves to alter their redox state through a respective induction of oxidative stress and generation of antioxidant defenses. The importance of therapeutic strategies that can uncouple these two divalent cations and modulate their ratio in favor of sustained antioxidant defenses is therefore suggested.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19333130      PMCID: PMC2802540          DOI: 10.1097/FJC.0b013e3181a15e77

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  57 in total

1.  Cytoprotective properties of nisoldipine and amlodipine against oxidative endothelial cell injury.

Authors:  I T Mak; J Zhang; W B Weglicki
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

Review 2.  Eukaryotic zinc transporters and their regulation.

Authors:  L A Gaither; D J Eide
Journal:  Biometals       Date:  2001 Sep-Dec       Impact factor: 2.949

3.  Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity.

Authors:  J W Tomlinson; B Sinha; I Bujalska; M Hewison; P M Stewart
Journal:  J Clin Endocrinol Metab       Date:  2002-12       Impact factor: 5.958

4.  Aldosterone-induced inflammation in the rat heart : role of oxidative stress.

Authors:  Yao Sun; Jiakun Zhang; Li Lu; Sue S Chen; Mark T Quinn; Karl T Weber
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

5.  Nitric oxide induces metallothionein (MT) gene expression apparently by displacing zinc bound to MT.

Authors:  K Katakai; J Liu; K Nakajima; L K Keefer; M P Waalkes
Journal:  Toxicol Lett       Date:  2001-02-28       Impact factor: 4.372

6.  Nitric oxide-induced changes in intracellular zinc homeostasis are mediated by metallothionein/thionein.

Authors:  Claudette M St Croix; K J Wasserloos; K E Dineley; I J Reynolds; E S Levitan; B R Pitt
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-02       Impact factor: 5.464

7.  Regulation of metallothionein gene expression by oxidative stress and metal ions.

Authors:  G K Andrews
Journal:  Biochem Pharmacol       Date:  2000-01-01       Impact factor: 5.858

Review 8.  Cellular zinc sensors: MTF-1 regulation of gene expression.

Authors:  G K Andrews
Journal:  Biometals       Date:  2001 Sep-Dec       Impact factor: 2.949

9.  Mitochondrial sequestration and Ca(2+)-dependent release of cytosolic Zn(2+) loads in cortical neurons.

Authors:  Stefano L Sensi; Dien Ton-That; John H Weiss
Journal:  Neurobiol Dis       Date:  2002-07       Impact factor: 5.996

10.  Glutathione oxidation as a trigger of mitochondrial depolarization and oscillation in intact hearts.

Authors:  Martin K Slodzinski; Miguel A Aon; Brian O'Rourke
Journal:  J Mol Cell Cardiol       Date:  2008-08-07       Impact factor: 5.000

View more
  30 in total

1.  Congestive heart failure: where homeostasis begets dyshomeostasis.

Authors:  German Kamalov; Syamal K Bhattacharya; Karl T Weber
Journal:  J Cardiovasc Pharmacol       Date:  2010-09       Impact factor: 3.105

2.  Calcium and zinc dyshomeostasis during isoproterenol-induced acute stressor state.

Authors:  Atta U Shahbaz; Tieqiang Zhao; Wenyuan Zhao; Patti L Johnson; Robert A Ahokas; Syamal K Bhattacharya; Yao Sun; Ivan C Gerling; Karl T Weber
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-12       Impact factor: 4.733

Review 3.  Atrophied cardiomyocytes and their potential for rescue and recovery of ventricular function.

Authors:  Mark R Heckle; David M Flatt; Yao Sun; Salvatore Mancarella; Tony N Marion; Ivan C Gerling; Karl T Weber
Journal:  Heart Fail Rev       Date:  2016-03       Impact factor: 4.214

Review 4.  Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling.

Authors:  Fadia Mayyas; Karem H Alzoubi; David R Van Wagoner
Journal:  Int J Cardiol       Date:  2013-08-15       Impact factor: 4.164

5.  Enhanced resistance to permeability transition in interfibrillar cardiac mitochondria in dogs: effects of aging and long-term aldosterone infusion.

Authors:  Girma Asemu; Kelly A O'Connell; James W Cox; Erinne R Dabkowski; Wenhong Xu; Rogerio F Ribeiro; Kadambari C Shekar; Peter A Hecker; Sharad Rastogi; Hani N Sabbah; Charles L Hoppel; William C Stanley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-15       Impact factor: 4.733

Review 6.  Disturbances in calcium metabolism and cardiomyocyte necrosis: the role of calcitropic hormones.

Authors:  Jawwad Yusuf; M Usman Khan; Yaser Cheema; Syamal K Bhattacharya; Karl T Weber
Journal:  Prog Cardiovasc Dis       Date:  2012 Jul-Aug       Impact factor: 8.194

7.  Molecular and Cellular Effect of Angiotensin 1-7 on Hypertensive Kidney Disease.

Authors:  Yuanjian Chen; Wenyuan Zhao; Chang Liu; Weixin Meng; Tieqiang Zhao; Syamal K Bhattacharya; Yao Sun
Journal:  Am J Hypertens       Date:  2019-04-22       Impact factor: 2.689

8.  Reverse remodeling and recovery from cachexia in rats with aldosteronism.

Authors:  Yaser Cheema; Wenyuan Zhao; Tieqiang Zhao; M Usman Khan; Kelly D Green; Robert A Ahokas; Ivan C Gerling; Syamal K Bhattacharya; Karl T Weber
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-06-22       Impact factor: 4.733

9.  Small dedifferentiated cardiomyocytes bordering on microdomains of fibrosis: evidence for reverse remodeling with assisted recovery.

Authors:  Fahed Al Darazi; Wenyuan Zhao; Tieqiang Zhao; Yao Sun; Tony N Marion; Robert A Ahokas; Syamal K Bhattacharya; Ivan C Gerling; Karl T Weber
Journal:  J Cardiovasc Pharmacol       Date:  2014-09       Impact factor: 3.105

10.  Uncoupling the coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria seen in aldosteronism.

Authors:  German Kamalov; Robert A Ahokas; Wenyuan Zhao; Tieqiang Zhao; Atta U Shahbaz; Patti L Johnson; Syamal K Bhattacharya; Yao Sun; Ivan C Gerling; Karl T Weber
Journal:  J Cardiovasc Pharmacol       Date:  2010-03       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.